These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 3896657

  • 1. The effects of piretanide on catecholamine metabolism, plasma renin activity and plasma aldosterone: a double-blind study versus furosemide in healthy volunteers.
    Verho M, Heintz B, Nelson K, Kirsten R.
    Curr Med Res Opin; 1985; 9(7):461-74. PubMed ID: 3896657
    [Abstract] [Full Text] [Related]

  • 2. The effects of piretanide on catecholamine metabolism, plasma renin activity and serum aldosterone: a double-blind pilot comparison against hydrochlorothiazide in patients with essential hypertension.
    Verho M, Kirsten R, Bückert C.
    Pharmatherapeutica; 1984; 3(9):595-606. PubMed ID: 6374680
    [Abstract] [Full Text] [Related]

  • 3. Urocortin 2 inhibits furosemide-induced activation of renin and enhances renal function and diuretic responsiveness in experimental heart failure.
    Rademaker MT, Charles CJ, Nicholls MG, Richards AM.
    Circ Heart Fail; 2009 Nov; 2(6):532-40. PubMed ID: 19919977
    [Abstract] [Full Text] [Related]

  • 4. Time-dependent effects of low-dose aspirin on plasma renin activity, aldosterone, cortisol, and catecholamines.
    Snoep JD, Hovens MM, Pasha SM, Frölich M, Pijl H, Tamsma JT, Huisman MV.
    Hypertension; 2009 Nov; 54(5):1136-42. PubMed ID: 19805643
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Differential regulation of collecting duct Na+, K+-ATPase and K+ excretion by furosemide and piretanide: role of bradykinin.
    Buffin-Meyer B, Younes-Ibrahim M, El Mernissi G, Cheval L, Marsy S, Grima M, Girolami JP, Doucet A.
    J Am Soc Nephrol; 2004 Apr; 15(4):876-84. PubMed ID: 15034089
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effects of the calcium antagonist felodipine on the sympathetic and renin-angiotensin-aldosterone systems in essential hypertension.
    Katzman PL, Hulthén UL, Hökfelt B.
    Acta Med Scand; 1988 Apr; 223(2):125-31. PubMed ID: 3279724
    [Abstract] [Full Text] [Related]

  • 9. Additive effects of a sodium chloride restricted diet and furosemide administration in healthy dogs.
    Lovern CS, Swecker WS, Lee JC, Moon ML.
    Am J Vet Res; 2001 Nov; 62(11):1793-6. PubMed ID: 11703026
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Variance comparison as a tool in clinical pharmacology: an example with two loop diuretics.
    Imbs JL, Schmidt M, Spriet A, Schwartz J.
    Eur J Clin Pharmacol; 1982 Nov; 23(3):221-4. PubMed ID: 6756934
    [Abstract] [Full Text] [Related]

  • 12. Long term treatment of moderate hypertension with penbutolol (Hoe 893d). I. Effects on blood pressure, pulse rate, catecholamines in blood and urine, plasma renin activity and urinary aldosterone under basal conditions and following exercise.
    Hansson BG, Hökfelt B.
    Eur J Clin Pharmacol; 1975 Oct 10; 9(1):9-19. PubMed ID: 9298
    [Abstract] [Full Text] [Related]

  • 13. Plasma atrial natriuretic peptide and the renin-aldosterone system during long-term administration of the diuretic xipamide in man.
    Lijnen P, Hespel P, Fagard R, Staessen J, Goossens W, Lissens W, Amery A.
    Eur J Clin Pharmacol; 1989 Oct 10; 36(2):111-7. PubMed ID: 2524386
    [Abstract] [Full Text] [Related]

  • 14. Effects of furosemide, piretanide, and water loading on urinary excretion of cefazolin in humans.
    Morgant C, Contrepois A, Chau NP, Romaru A, Fourtillan JB, Carbon C.
    Antimicrob Agents Chemother; 1984 May 10; 25(5):618-21. PubMed ID: 6732228
    [Abstract] [Full Text] [Related]

  • 15. Comparison between the effects of torsemide and furosemide on the renin-angiotensin-aldosterone system of normal dogs.
    Potter BM, Ames MK, Hess A, Poglitsch M.
    J Vet Cardiol; 2019 Dec 10; 26():51-62. PubMed ID: 31809955
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Comparison of intravenous piretanide and furosemide in patients with congestive heart failure.
    Marsh JD, Nesto R, Glynn MA, Smith TW.
    J Cardiovasc Pharmacol; 1982 Dec 10; 4(6):949-54. PubMed ID: 6185787
    [Abstract] [Full Text] [Related]

  • 18. Mechanisms of reduced effects of loop diuretics in healthy volunteers and in patients with renal disease.
    Sjöström P.
    Scand J Urol Nephrol Suppl; 1988 Dec 10; 111():1-66. PubMed ID: 3201162
    [Abstract] [Full Text] [Related]

  • 19. Pharmacological evaluation of hydroxypropylcellulose-ethylcellulose microcapsules containing piretanide.
    Tsujiyama T, Suzuki N, Kuriki T, Kawata M, Goto S.
    J Pharmacobiodyn; 1990 Jan 10; 13(1):1-9. PubMed ID: 2187973
    [Abstract] [Full Text] [Related]

  • 20. The effect of enalapril on furosemide-activated renin-angiotensin-aldosterone system in healthy dogs.
    Lantis AC, Ames MK, Werre S, Atkins CE.
    J Vet Pharmacol Ther; 2015 Oct 10; 38(5):513-7. PubMed ID: 25771846
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.